Paradigm Biocapital Advisors LP

13F Holdings History for AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO)

Symbol: AGIO on Nasdaq
Investment type: Equity / Common Stock, $0.001 par value per share
Latest Disclosed Ownership: 2.87M shares
Security Ownership: 4.9%

Shares, Excluding Options vs Price

Value, Excluding Options

Paradigm BioCapital Advisors LP ownership in AGIOS PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share (AGIO)

2025-11-14 - Paradigm BioCapital Advisors LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2.87M shares of AGIOS PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share (AGIO). This represents 4.9% percent ownership of the company. In their previous filing dated 2025-08-28, Paradigm Biocapital Advisors LP had reported owning 3.03M shares, indicating a decrease of -5.1% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Paradigm BioCapital Advisors LP	4.9%	-6%	$115M	2.87M	-154,422	-5.1%	$40.14	13G/A	9/30/2025	14 Nov 2025 16:34:22
Paradigm BioCapital Advisors LP	5.2%		$119M	3.03M			$39.27	13G	8/21/2025	28 Aug 2025 16:31:10

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025		3.18%	+1.82%	$107M	2.67M	+1,531,044	+134%	$40.14	Q3 2025
9/30/2025	call	5.88%	+5.88%	$8.03M	200K	+200,000	NEW	$40.14	Q3 2025
6/30/2025		1.62%	+1.62%	$38M	1.14M	+1,142,511	NEW	$33.26	Q2 2025
3/31/2025			-0.32%	$0	0	-276,439	-100%		Q1 2025
12/31/2024		0.32%	+0.32%	$9.08M	276K	+276,439	NEW	$32.86	Q4 2024
6/30/2024			-0.42%	$0	0	-400,000	-100%		Q2 2024
3/31/2024		0.41%	+0.55%	$11.7M	400K	+400,000	NEW	$29.24	Q1 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.